A phase 3 trial of Johnson & Johnson's TAR-200 therapy in bladder cancer has failed to show efficacy, although the company is still confident in the potential of the programme. The SunRISe-2 study, in ...

In a bid to put litigation over the safety of its talc products into the rearview mirror, Johnson & Johnson has added another $1.1 billion to its settlement offer, according to media reports. Citing ...

Harry Potter series author J.K. Rowling first came under fire in early June 2020 for controversial tweets she posted about the transgender community. Her stance has caused fans and stars of the ...

Five years later, Rowling’s anti-trans rhetoric has only become more extreme as the author continues to publicly support anti-trans legislation and even take aim at the asexual community. Here’s ...